PetVivo Holdings, Inc.’s interview with Mr. John Lai, CEO / President.


New to The Street T.V. re-airs Mr. John Lai, CEO / President, PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW), in-studio Nasdaq Marketplace interview with T.V. Anchor Jane King. John provides viewers with his corporate updates. The injectable patented Spryng with OsteoCushion Technology treats osteoarthritis and joint afflictions while providing rehabilitation treatments for horses and dogs and continues to grow as a reliable treatment. Veterinarians see continued successes, and dog and horse owners see excellent results with less pain and more mobilities. Since Spryng mimics cartilage and lasts about 1-year per injection, competitor products appear to be no match in cost-benefit comparisons. PETV’s corporate studies continue between Spryng and competitors’ products, giving veterinarians empirical, comprehensive, and marketable data. John talks about hiring seasoned personnel who became regional managers so the Company can handle and expand its growth. John announces its upcoming launch of, a website dedicated to donating the Spryng product to charitable non-profit animal rescues and assistance organizations. “Word of Mouth” and conference participations seem to be the best form of marketing PETV’s Spryng with OsteoCushion Technology. Soon, PetVivo is rolling out its feline product for cats with osteoarthritis. This interview segment initially aired on April 10, 2022.

To make sure you never miss a video from New to the Street, click here to subscribe:

Follow New to the Street on Twitter:

Follow New to the Street on Facebook:

Follow New to the Street on Instagram:

Follow New to the Street on Rumble:

About New to the Street:

Subscribe to our Mailing List: